Both Epac and PKA are effectors of the second messenger cAMP. Utilizing an Epac pathway-specific cAMP analogue (ESCA), we previously reported that Epac signaling regulates proglucagon gene (gcg) expression in glucagon-like peptide-1 (GLP-1)-producing intestinal endocrine L cell lines, GLUTag and STC-1. We now show that Epac-2 is also expressed in glucagon-producing pancreatic cell lines, including PKA-deficient InR1-G9 cells, and that ESCA stimulates gcg promoter and mRNA expression in the InR1-G9 cells. Employing a dominant-negative Epac-2 expression plasmid (Epac-2DN), we found that Epac inhibition attenuated forskolin-stimulated gcg promoter expression in the PKA-active STC-1 cell line, and blocked forskolin-stimulated gcg promoter expression in the InR1-G9 cells. Consistently, ESCA was shown to stimulate glucagon and GLP-1 production in the InR1-G9 and GLUTag cell lines, respectively. Surprisingly, ESCA treatment did not show a notable stimulation of glucagon or GLP-1 secretion from these two cell lines. This is in contrast to its ability to stimulate insulin secretion from the pancreatic Ins-1 cell line. Our findings suggest that Epac is selectively involved in peptide hormone secretion in pancreatic and intestinal endocrine cells, and distinct signaling cascades are involved in stimulating production versus secretion of glucagon and GLP-1 in response to cAMP elevation.